The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Clesrovimab is a single-dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Credit: Sergiy Palamarchuk ...

Amylyx Pharmaceuticals has announced positive results from the trial, indicating sustained improvements with AMX0035 in ...

Response Pharmaceuticals has initiated subject enrolment for a Phase II trial of its drug candidate RDX-002, designed to ...

Integrated clinical trial network Eximia Research has expanded into Iowa, US, with the acquisition of Integrated Clinical ...

As of 5 October 2024, a total of 17,579 pertussis cases had been reported in residents in the US (excluding territories).

NovoCure’s Optune Lua, a wearable indicated for patients with metastatic non-small cell lung cancer has received approval ...

The upcoming two-day event delves into the clinical trial landscape and the strategies employed to increase the region’s ...

Genprex received approval to proceed to the highest dose in the Phase I Acclaim-3 trial of Reqorsa for ES-small cell lung ...

The trial demonstrated a median reduction in EEG seizure burden Credit: Ground Picture/Shutterstock. Marinus Pharmaceuticals has reported results from the pivotal Phase III RAISE trial for intravenous ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...